MedPath

ALCON RESEARCH

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Safety and Efficacy Evaluation of a New Contact Lens Disinfecting Solution in Gas Permeable Contact Lens Wearers

Not Applicable
Completed
Conditions
Astigmatism
Myopia
Refractive Error
Hyperopia
Interventions
Device: FID 120947A contact lens disinfecting solution
Device: Boston Simplus multi-action solution
Device: Gas permeable contact lenses
First Posted Date
2013-07-31
Last Posted Date
2015-06-30
Lead Sponsor
Alcon Research
Target Recruit Count
112
Registration Number
NCT01912781

Proof-of-Concept Study of a Single Application of an Investigational Otic Suspension in Treatment of Acute Otitis Media With Tympanostomy Tubes

Phase 2
Terminated
Conditions
Acute Otitis Media
Interventions
First Posted Date
2013-07-26
Last Posted Date
2017-12-06
Lead Sponsor
Alcon Research
Target Recruit Count
84
Registration Number
NCT01908803

Pharmacokinetic Study of AL-60371 Otic Suspension in Pediatric Subjects Following Tympanostomy Tube Surgery

Phase 1
Withdrawn
Conditions
Otitis Media
Interventions
Drug: AL-60371 otic suspension
First Posted Date
2013-07-26
Last Posted Date
2016-03-08
Lead Sponsor
Alcon Research
Registration Number
NCT01908764

Multi-Center Clinical Evaluation of Two Daily Disposable Contact Lenses

Not Applicable
Completed
Conditions
Refractive Error
Myopia
Interventions
Device: Ultrafilcon B contact lens
Device: Stenfilcon A contact lens
First Posted Date
2013-07-12
Last Posted Date
2015-05-12
Lead Sponsor
Alcon Research
Target Recruit Count
89
Registration Number
NCT01898260
Locations
🇬🇧

Alcon Investigative Site, Surrey, United Kingdom

A Phase III Study of A01016 in Subjects With Symptomatic Vitreomacular Adhesion

Phase 3
Completed
Conditions
Symptomatic Vitreomacular Adhesion
Interventions
Drug: Sham injection
Drug: Ocriplasmin
First Posted Date
2013-06-28
Last Posted Date
2015-11-30
Lead Sponsor
Alcon Research
Target Recruit Count
251
Registration Number
NCT01889251
Locations
🇯🇵

Contact Alcon for Trial Locations, Tokyo, Japan

Nepafenac Once Daily for Macular Edema - Study 2

Phase 3
Completed
Conditions
Non-Proliferative Diabetic Retinopathy
Cataract
Interventions
First Posted Date
2013-06-07
Last Posted Date
2016-08-02
Lead Sponsor
Alcon Research
Target Recruit Count
819
Registration Number
NCT01872611

Lid Wiper Epitheliopathy Trial

Not Applicable
Terminated
Conditions
Lid Wiper Epitheliopathy
Interventions
Device: Etafilcon A contact lenses
Device: Spectacles
Device: Delefilcon A contact lenses
First Posted Date
2013-06-06
Last Posted Date
2014-10-29
Lead Sponsor
Alcon Research
Target Recruit Count
187
Registration Number
NCT01870856

Clinical Evaluation of Systane® ULTRA Compared to OPTIVE® in Ocular Surface Staining

Not Applicable
Completed
Conditions
Dry Eye Syndrome
Interventions
Other: Preservative-free saline solution eyedrops
Other: Systane® ULTRA lubricant eyedrops
Other: OPTIVE® lubricating eyedrops
First Posted Date
2013-05-27
Last Posted Date
2015-08-04
Lead Sponsor
Alcon Research
Target Recruit Count
105
Registration Number
NCT01863368

Pharmacokinetic Evaluation of Moxifloxacin in Vigadexa® in Aqueous Humor Samples Following Preoperative Antibiotic/Steroid Dosing in Cataract Surgery Patients

Phase 4
Completed
Conditions
Cataract
Interventions
First Posted Date
2013-05-22
Last Posted Date
2013-08-07
Lead Sponsor
Alcon Research
Target Recruit Count
36
Registration Number
NCT01859702

Visual Performance Investigation of Two Toric Soft Contact Lenses

Not Applicable
Completed
Conditions
Refractive Error
Myopia
Astigmatism
Hyperopia
Interventions
Device: Lotrafilcon B toric contact lens
Device: Comfilcon A toric contact lens
First Posted Date
2013-05-21
Last Posted Date
2014-10-22
Lead Sponsor
Alcon Research
Target Recruit Count
49
Registration Number
NCT01858701
© Copyright 2025. All Rights Reserved by MedPath